practical synthesis prostratin dpp analogs adjuvant leads latent hiv
although antiretroviral therapies effective decreasing active viral loads aids patients persistence latent viral reservoirs prevents eradication virus prostratin dpp deoxyphorbol phenylacetate activate latent virus thus represent promising adjuvants antiviral therapy limited supply challenges accessing related structures however impeded therapeutic development search clinically superior analogs report practical synthesis prostratin dpp starting phorbol crotophorbolone agents readily available renewable sources including biodiesel candidate synthesis reliably supplies gram quantities therapeutically promising natural products hitherto available low variable amounts natural sources opens access variety new analogs
